Jazz Pharmaceuticals Officer Patricia Carr Files Form 144 to Sell $327K in Common Stock

Overview

On November 4, 2026, Patricia Carr, an Officer of Jazz Pharmaceuticals plc ($JAZZ), submitted a Form 144 notice disclosing an intention to sell 1,413 shares of common stock with an aggregate market value of approximately $326,909.51.

Transaction Details

• Securities to be Sold: 1,413 common shares.
• Aggregate Market Value: $326,909.51 (implied price of ~$231.36 per share).
• Securities Acquired:
  • 1,250 shares acquired on 11/04/2026 via a stock option exercise paid in cash.
  • 163 shares acquired on 05/29/2026 via the Employee Stock Purchase Plan (ESPP) paid in cash.
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
• Past 3 Months Activity: None reported.

Trading Significance

This planned disposition is categorized as Low significance. The shares being sold stem entirely from employee equity compensation (a same-day option exercise and earlier ESPP participation). The transaction volume of 1,413 shares represents a negligible fraction of the company's 64,189,052 outstanding shares and falls within routine executive equity compensation management.